GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies

por Nguyen, Khoa, McConnell, Emily, Edwards, Orielle, Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2022

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

por Nguyen, Khoa, Alzoubi, Madlin, Hebert, Katherine, Cheng, Thomas, Elliott, Steven, Burow, Matthew, Collins-Burow, Bridgette
Publicado 2021

Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy

por Dong, Shengli, Matossian, Margarite D., Yousefi, Hassan, Khosla, Maninder, Collins-Burow, Bridgette M., Burow, Matthew E., Alahari, Suresh K.
Publicado 2023

Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cells

por Li, Miao, Li, Xi, Zhuang, Yan, Wang, Yan, Burow, Matthew E., Collins-Burow, Bridgette, Xue, Min, Song, Chengjie, Shan, Bin
Publicado 2016

436 Examining the Role of Obesity and Leptin Signaling in Triple Negative Breast Cancer

por Brock, Courtney, Wright, Maryl K., Nguyen, Khoa, Hebert, Katherine, Alzoubi, Madlin, Cheng, Thomas, Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2022

235 Analysiss of TNBC Cell Lines Cultured a Novel Translational Breast Cancer Microphysiological System (BC-MPS)

por Hebert, Katherine L., Nguyen, Khoa, Cheng, Thomas, Alzoubi, Madlin, Elliott, Steven, Collins-Burow, Bridgette, Martin, Elizabeth, Lau, Frank, Burow, Matthew
Publicado 2022

Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line

por Martin, Elizabeth C., Bratton, Melyssa R., Zhu, Yun, Rhodes, Lyndsay V., Tilghman, Syreeta L., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2012

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

por Tate, Chandra R, Rhodes, Lyndsay V, Segar, H Chris, Driver, Jennifer L, Pounder, F Nell, Burow, Matthew E, Collins-Burow, Bridgette M
Publicado 2012

miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling

por Martin, Elizabeth C., Krebs, Adrienne E., Burks, Hope E., Elliott, Steven, Baddoo, Melody, Collins-Burow, Bridgette M., Flemington, Erik K., Burow, Matthew E.
Publicado 2014

Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment

por Nguyen, Khoa, Rivera, Andrew, Alzoubi, Madlin, Wathieu, Henri, Dong, Shengli, Yousefi, Hassan, Matossian, Margarite, Alahari, Suresh, Drewry, David, Burow, Matthew, Collins-Burow, Bridgette
Publicado 2021

NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types

por Nguyen, Khoa, Boehling, Julia, Tran, Minh N., Cheng, Thomas, Rivera, Andrew, Collins-Burow, Bridgette M., Lee, Sean B., Drewry, David H., Burow, Matthew E.
Publicado 2023

microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

por Martin, Elizabeth C, Rhodes, Lyndsay V, Elliott, Steven, Krebs, Adrienne E, Nephew, Kenneth P, Flemington, Erik K, Collins-Burow, Bridgette M, Burow, Matthew E
Publicado 2014

Ceritinib is a novel triple negative breast cancer therapeutic agent

por Dong, Shengli, Yousefi, Hassan, Savage, Isabella Van, Okpechi, Samuel C., Wright, Maryl K., Matossian, Margarite D., Collins-Burow, Bridgette M., Burow, Matthew E., Alahari, Suresh K.
Publicado 2022

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

por Zhou, Changhua, Zhong, Qiu, Rhodes, Lyndsay V, Townley, Ian, Bratton, Melyssa R, Zhang, Qiang, Martin, Elizabeth C, Elliott, Steven, Collins-Burow, Bridgette M, Burow, Matthew E, Wang, Guangdi
Publicado 2012

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

por Rhodes, Lyndsay V., Martin, Elizabeth C., Segar, H. Chris, Miller, David F. B., Buechlein, Aaron, Rusch, Douglas B., Nephew, Kenneth P., Burow, Matthew E., Collins-Burow, Bridgette M.
Publicado 2015

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model

por Matossian, Margarite D., Burks, Hope E., Elliott, Steven, Hoang, Van T., Bowles, Annie C., Sabol, Rachel A., Bunnell, Bruce A., Martin, Elizabeth C., Burow, Matthew E., Collins-Burow, Bridgette M.
Publicado 2018

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast c...

por Matossian, Margarite D., Elliott, Steven, Rhodes, Lyndsay V., Martin, Elizabeth C., Hoang, Van T., Burks, Hope E., Zuercher, William J., Drewry, David H., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2021

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition

por ANTOON, JAMES W., NITZCHKE, ASHLEY M., MARTIN, ELIZABETH C., RHODES, LYNDSAY V., NAM, SEUNGYOON, WADSWORTH, SCOTT, SALVO, VIRGILO A., ELLIOTT, STEVEN, COLLINS-BUROW, BRIDGETTE, NEPHEW, KENNETH P., BUROW, MATTHEW E.
Publicado 2013

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes

por Matossian, Margarite D., Elliott, Steven, Hoang, Van T., Burks, Hope E., Phamduy, Theresa B., Chrisey, Douglas B., Zuercher, William J., Drewry, David H., Wells, Carrow, Collins-Burow, Bridgette, Burow, Matthew E.
Publicado 2017

Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast Tissue

por Gurrala, Rakesh, Byrne, C. Ethan, Brown, Loren M., Tiongco, Rafael Felix P., Matossian, Margarite D., Savoie, Jonathan J., Collins-Burow, Bridgette M., Burow, Matthew E., Martin, Elizabeth C., Lau, Frank H.
Publicado 2021